It’s a summer Friday afternoon at the Lab’s Dorothy McKibbin Conference Center in Santa Fe, and a team of six data scientists from across the Lab has just finished presenting the results of their ...

"With our big data study, we wanted to find out which molecular players are behind these disease-causing processes." The study was based on extensive multi-omics data sets from over 1,300 people with ...

Wall Street quants and leading financial academics are clashing over whether artificial intelligence has upended one of the core principles of systematic investing. Quant traders, who use rules-based ...

Aug 19 (Reuters) - Viking Therapeutics (VKTX.O), opens new tab said Tuesday its experimental weight-loss pill helped patients lose 12.2% of their body weight in a mid-stage trial, missing Wall ...

AI's been listening and the data shows which jobs might be next. For the engineering profession, which has long been seen as the engine of innovation, the AI revolution poses a dilemma: Will ...

Travis Gettys is a senior editor for Raw Story based in northern Kentucky. He previously worked as a web editor for WLWT-TV and a contributing writer for the Kentucky Enquirer, and he also wrote for ...

After a spring and summer of wet conditions throughout almost the entire state, drought is returning to Missouri. “We hadn't had a week in July or August with a map that had no (drought) since 2019, ...

The decision cited a Supreme Court order in June granting DOGE analysts sweeping access to other data stored at the Social Security Administration. By Zach Montague Reporting from Washington A federal ...

What if you could cut hours of tedious work from your day while uncovering insights that could transform your decision-making? For analysts, this isn’t just wishful thinking—it’s the reality that ...

Every year, HBO picks a team to follow throughout camp, and this season is all about the Bills. Usually, Hard Knocks has a good amount of drama to it. In 2018, the Cleveland Browns were the featured ...

Orforglipron cut weight by 12.4% vs. 0.9% with placebo, below 15% expectations. BofA lowered Eli Lilly's price forecast to $900 but kept a Buy rating after earnings beat. Tonight: Get a FREE TRADE, ...